Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
By launching a low-cost, compounded oral version of semaglutide, Hims & Hers has undercut branded GLP-1 drugs by a wide margin, forcing investors to reassess the durability of Big Pharmas pricing power
Wegovy was approved in 2021 for weight loss and contains the active ingredient semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist
Its about saving lives
WHOPPA enables parallel assessment of leucine-rich repeat kinase 2 and glucocerebrosidase enzymatic activity in Parkinsons disease monocytes
PubMed Central, Moretti, Rita, and Paola Caruso
Speaker's bureau: Novo Nordisk, AstraZeneca Funding None
US$ 27.55
US$ 21.02
US$ 21.28
US$ 23.11
US$ 27.38
US$ 28.96
